Literature DB >> 23803944

Drug safety: double jeopardy.

Mary Carmichael.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23803944     DOI: 10.1038/498S14a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

Review 1.  Clinical practice. Adult primary care after childhood acute lymphoblastic leukemia.

Authors:  Lisa Diller
Journal:  N Engl J Med       Date:  2011-10-13       Impact factor: 91.245

2.  Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.

Authors:  Javier G Blanco; Can-Lan Sun; Wendy Landier; Lu Chen; Diego Esparza-Duran; Wendy Leisenring; Allison Mays; Debra L Friedman; Jill P Ginsberg; Melissa M Hudson; Joseph P Neglia; Kevin C Oeffinger; A Kim Ritchey; Doojduen Villaluna; Mary V Relling; Smita Bhatia
Journal:  J Clin Oncol       Date:  2011-11-28       Impact factor: 44.544

3.  Identification of the molecular basis of doxorubicin-induced cardiotoxicity.

Authors:  Sui Zhang; Xiaobing Liu; Tasneem Bawa-Khalfe; Long-Sheng Lu; Yi Lisa Lyu; Leroy F Liu; Edward T H Yeh
Journal:  Nat Med       Date:  2012-10-28       Impact factor: 53.440

4.  ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.

Authors:  Giuseppe Sacco; Bigioni Mario; Giuseppe Lopez; Stefano Evangelista; Stefano Manzini; Carlo Alberto Maggi
Journal:  Vascul Pharmacol       Date:  2009 May-Jun       Impact factor: 5.773

5.  Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia: a report from the Childhood Cancer Survivor Study.

Authors:  Daniel A Mulrooney; Douglas C Dover; Suwen Li; Yutaka Yasui; Kirsten K Ness; Ann C Mertens; Joseph P Neglia; Charles A Sklar; Leslie L Robison; Stella M Davies
Journal:  Cancer       Date:  2008-05-01       Impact factor: 6.860

  5 in total
  1 in total

1.  Pharmacovigilance for children's sake.

Authors:  Kristina Star; I Ralph Edwards
Journal:  Drug Saf       Date:  2014-02       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.